Treace Medical Concepts, Inc.
US ˙ NasdaqGS ˙ US89455T1097

Introduction

This page provides a comprehensive analysis of the known insider trading history of Scanlan Sean F.. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

Companies with Reported Insider Positions

The SEC filings indicate Scanlan Sean F. has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:TMCI / Treace Medical Concepts, Inc. Chief Innovation Officer 373,807
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by Scanlan Sean F.. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Purchases TMCI / Treace Medical Concepts, Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in TMCI / Treace Medical Concepts, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

TMCI / Treace Medical Concepts, Inc. Insider Trades
Insider Sales TMCI / Treace Medical Concepts, Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in TMCI / Treace Medical Concepts, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
2023-03-09 TMCI Scanlan Sean F. 505 24.4100 505 24.4100 12,327 249 6.0300 -9,282 -75.30

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

TMCI / Treace Medical Concepts, Inc. Insider Trades
Insider Trading History

This table shows the complete list of insider trades made by Scanlan Sean F. as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change
Share
Price
Tran
Value
Remaining
Value
2025-08-12 2025-08-09 4 TMCI TREACE MEDICAL CONCEPTS, INC.
Common Stock
F - Taxes -9,814 373,807 -2.56
2025-07-22 2025-07-18 4 TMCI TREACE MEDICAL CONCEPTS, INC.
Common Stock
M - Exercise 33,437 383,621 9.55 0.72 24,001 275,363
2025-03-19 2025-03-17 4 TMCI TREACE MEDICAL CONCEPTS, INC.
Common Stock
S - Sale X -50,000 364,081 -12.07 7.97 -398,460 2,901,434
2025-03-19 2025-03-17 4 TMCI TREACE MEDICAL CONCEPTS, INC.
Common Stock
M - Exercise X 50,000 414,081 13.73 1.05 52,500 434,785
2025-03-11 2025-03-10 4 TMCI TREACE MEDICAL CONCEPTS, INC.
Common Stock
F - Taxes -1,396 364,081 -0.38
2025-03-11 2025-03-08 4 TMCI TREACE MEDICAL CONCEPTS, INC.
Common Stock
F - Taxes -401 365,477 -0.11
2025-01-24 2025-01-22 4 TMCI TREACE MEDICAL CONCEPTS, INC.
Common Stock
A - Award 140,625 365,878 62.43
2025-01-14 2025-01-10 4 TMCI TREACE MEDICAL CONCEPTS, INC.
Common Stock
F - Taxes -4,821 225,253 -2.10
2024-09-16 2024-09-12 4 TMCI TREACE MEDICAL CONCEPTS, INC.
Common Stock
M - Exercise 33,750 250,074 15.60 0.10 3,280 24,307
2024-08-09 2024-08-09 4 TMCI TREACE MEDICAL CONCEPTS, INC.
Common Stock
A - Award 120,900 216,324 126.70
2024-03-12 2024-03-10 4 TMCI TREACE MEDICAL CONCEPTS, INC.
Common Stock
F - Taxes -1,396 95,424 -1.44
2024-03-12 2024-03-08 4 TMCI TREACE MEDICAL CONCEPTS, INC.
Common Stock
F - Taxes -389 96,820 -0.40
2024-01-12 2024-01-10 4 TMCI TREACE MEDICAL CONCEPTS, INC.
Common Stock
A - Award 65,025 97,209 202.04
2023-11-03 2023-11-02 4 TMCI TREACE MEDICAL CONCEPTS, INC.
Common Stock
F - Taxes -211 32,184 -0.65
2023-05-18 2023-05-16 4 TMCI TREACE MEDICAL CONCEPTS, INC.
Common Stock
S - Sale X -25,000 32,395 -43.56 25.44 -635,978 824,100
2023-05-18 2023-05-16 4 TMCI TREACE MEDICAL CONCEPTS, INC.
Common Stock
M - Exercise X 25,000 57,395 77.17 0.10 2,500 5,740
2023-03-10 2023-03-10 4 TMCI TREACE MEDICAL CONCEPTS, INC.
Common Stock
A - Award 22,925 32,395 242.08
2023-03-10 2023-03-09 4 TMCI TREACE MEDICAL CONCEPTS, INC.
Common Stock
S - Sale -505 9,470 -5.06 24.41 -12,327 231,163
2023-02-17 2023-02-15 4 TMCI TREACE MEDICAL CONCEPTS, INC.
Common Stock
S - Sale X -25,000 9,975 -71.48 21.69 -542,235 216,352
2023-02-17 2023-02-15 4 TMCI TREACE MEDICAL CONCEPTS, INC.
Common Stock
M - Exercise X 25,000 34,975 250.63 0.10 2,500 3,498
2023-01-13 2023-01-12 4 TMCI TREACE MEDICAL CONCEPTS, INC.
Common Stock
S - Sale X -25,000 9,975 -71.48 25.57 -639,308 255,084
2023-01-13 2023-01-12 4 TMCI TREACE MEDICAL CONCEPTS, INC.
Common Stock
M - Exercise X 25,000 34,975 250.63 0.10 2,500 3,498
2022-11-16 2022-11-14 4 TMCI TREACE MEDICAL CONCEPTS, INC.
Common Stock
S - Sale X -25,000 9,975 -71.48 24.27 -606,680 242,065
2022-11-16 2022-11-14 4 TMCI TREACE MEDICAL CONCEPTS, INC.
Common Stock
M - Exercise X 25,000 34,975 250.63 0.10 2,500 3,498
2022-10-26 2022-10-24 4 TMCI TREACE MEDICAL CONCEPTS, INC.
Common Stock
A - Award 3,400 9,975 51.71
2022-03-10 2022-03-08 4 TMCI TREACE MEDICAL CONCEPTS, INC.
Stock Option (Right to Buy)
A - Award 50,650 50,650
2022-03-10 2022-03-08 4 TMCI TREACE MEDICAL CONCEPTS, INC.
Common Stock
A - Award 6,575 6,575
2022-03-04 2022-03-02 4 TMCI TREACE MEDICAL CONCEPTS, INC.
Stock Option (Right to Buy)
M - Exercise X -25,000 124,149 -16.76
2022-03-04 2022-03-02 4 TMCI TREACE MEDICAL CONCEPTS, INC.
Common Stock
S - Sale X -25,000 0 -100.00 20.82 -520,550
2022-03-04 2022-03-02 4 TMCI TREACE MEDICAL CONCEPTS, INC.
Common Stock
M - Exercise X 25,000 25,000 1.05 26,250 26,250
2022-02-10 2022-02-09 4 TMCI TREACE MEDICAL CONCEPTS, INC.
Stock Option (Right to Buy)
M - Exercise X -3,873 149,149 -2.53
2022-02-10 2022-02-09 4 TMCI TREACE MEDICAL CONCEPTS, INC.
Common Stock
S - Sale X -3,873 0 -100.00 20.16 -78,082
2022-02-10 2022-02-09 4 TMCI TREACE MEDICAL CONCEPTS, INC.
Common Stock
M - Exercise X 3,873 3,873 1.05 4,067 4,067
2022-02-10 2022-02-08 4 TMCI TREACE MEDICAL CONCEPTS, INC.
Stock Option (Right to Buy)
M - Exercise X -21,127 153,022 -12.13
2022-02-10 2022-02-08 4 TMCI TREACE MEDICAL CONCEPTS, INC.
Common Stock
S - Sale X -21,127 0 -100.00 20.02 -422,889
2022-02-10 2022-02-08 4 TMCI TREACE MEDICAL CONCEPTS, INC.
Common Stock
M - Exercise X 21,127 21,127 1.05 22,183 22,183
2022-01-12 2022-01-11 4 TMCI TREACE MEDICAL CONCEPTS, INC.
Stock Option (Right to Buy)
M - Exercise X -6,414 174,149 -3.55
2022-01-12 2022-01-11 4 TMCI TREACE MEDICAL CONCEPTS, INC.
Stock Option (Right to Buy)
M - Exercise X -2,424 33,820 -6.69
2022-01-12 2022-01-11 4 TMCI TREACE MEDICAL CONCEPTS, INC.
Common Stock
S - Sale X -8,838 0 -100.00 20.12 -177,846
2022-01-12 2022-01-11 4 TMCI TREACE MEDICAL CONCEPTS, INC.
Common Stock
M - Exercise X 6,414 8,838 264.60 1.05 6,735 9,280
2022-01-12 2022-01-11 4 TMCI TREACE MEDICAL CONCEPTS, INC.
Common Stock
M - Exercise X 2,424 2,424 1.57 3,806 3,806
2022-01-12 2022-01-10 4 TMCI TREACE MEDICAL CONCEPTS, INC.
Stock Option (Right to Buy)
M - Exercise X -30,631 36,244 -45.80
2022-01-12 2022-01-10 4 TMCI TREACE MEDICAL CONCEPTS, INC.
Stock Option (Right to Buy)
M - Exercise X -8,231 46,993 -14.90
2022-01-12 2022-01-10 4 TMCI TREACE MEDICAL CONCEPTS, INC.
Common Stock
S - Sale X -38,862 0 -100.00 20.16 -783,532
2022-01-12 2022-01-10 4 TMCI TREACE MEDICAL CONCEPTS, INC.
Common Stock
M - Exercise X 30,631 38,862 372.14 1.57 48,091 61,013
2022-01-12 2022-01-10 4 TMCI TREACE MEDICAL CONCEPTS, INC.
Common Stock
M - Exercise X 8,231 8,231 1.57 12,923 12,923
2022-01-05 2022-01-05 4 TMCI TREACE MEDICAL CONCEPTS, INC.
Stock Option (Right to Buy)
M - Exercise X -800 55,224 -1.43
2022-01-05 2022-01-05 4 TMCI TREACE MEDICAL CONCEPTS, INC.
Common Stock
S - Sale X -800 0 -100.00 20.02 -16,018
2022-01-05 2022-01-05 4 TMCI TREACE MEDICAL CONCEPTS, INC.
Common Stock
M - Exercise X 800 800 1.57 1,256 1,256
2022-01-05 2022-01-04 4 TMCI TREACE MEDICAL CONCEPTS, INC.
Stock Option (Right to Buy)
M - Exercise X -500 56,024 -0.88
2022-01-05 2022-01-04 4 TMCI TREACE MEDICAL CONCEPTS, INC.
Common Stock
S - Sale X -500 0 -100.00 20.00 -10,000
2022-01-05 2022-01-04 4 TMCI TREACE MEDICAL CONCEPTS, INC.
Common Stock
M - Exercise X 500 500 1.57 785 785
2022-01-05 2022-01-03 4 TMCI TREACE MEDICAL CONCEPTS, INC.
Stock Option (Right to Buy)
M - Exercise X -1,000 56,524 -1.74
2022-01-05 2022-01-03 4 TMCI TREACE MEDICAL CONCEPTS, INC.
Common Stock
S - Sale X -1,000 0 -100.00 20.02 -20,021
2022-01-05 2022-01-03 4 TMCI TREACE MEDICAL CONCEPTS, INC.
Common Stock
M - Exercise X 1,000 1,000 1.57 1,570 1,570
2021-11-12 2021-11-10 4 TMCI TREACE MEDICAL CONCEPTS, INC.
Stock Option (Right to Buy)
M - Exercise X -25,000 57,524 -30.29
2021-11-12 2021-11-10 4 TMCI TREACE MEDICAL CONCEPTS, INC.
Common Stock
S - Sale X -440 0 -100.00 22.20 -9,767
2021-11-12 2021-11-10 4 TMCI TREACE MEDICAL CONCEPTS, INC.
Common Stock
S - Sale X -24,560 440 -98.24 21.53 -528,664 9,471
2021-11-12 2021-11-10 4 TMCI TREACE MEDICAL CONCEPTS, INC.
Common Stock
M - Exercise X 25,000 25,000 1.57 39,250 39,250
2021-04-26 2021-04-22 4 TMCI TREACE MEDICAL CONCEPTS, INC.
Stock Option (Right to Buy)
A - Award 66,875 66,875
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)